MA29103B1 - Agents cytotoxiques comprenant de nouveaux taxanes - Google Patents

Agents cytotoxiques comprenant de nouveaux taxanes

Info

Publication number
MA29103B1
MA29103B1 MA30008A MA30008A MA29103B1 MA 29103 B1 MA29103 B1 MA 29103B1 MA 30008 A MA30008 A MA 30008A MA 30008 A MA30008 A MA 30008A MA 29103 B1 MA29103 B1 MA 29103B1
Authority
MA
Morocco
Prior art keywords
cytotoxic agents
new taxanes
taxanes
new
cytotoxic
Prior art date
Application number
MA30008A
Other languages
English (en)
Inventor
Michael L Miller
Ravi V J Chari
Erkan Baloglu
Alain Commercon
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34931583&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MA29103(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of MA29103B1 publication Critical patent/MA29103B1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/06—Peri-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Plural Heterocyclic Compounds (AREA)
MA30008A 2004-12-07 2007-06-18 Agents cytotoxiques comprenant de nouveaux taxanes MA29103B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP04292898A EP1669358A1 (fr) 2004-12-07 2004-12-07 Agents cytotoxiques comprenant des nouveau taxanes

Publications (1)

Publication Number Publication Date
MA29103B1 true MA29103B1 (fr) 2007-12-03

Family

ID=34931583

Family Applications (1)

Application Number Title Priority Date Filing Date
MA30008A MA29103B1 (fr) 2004-12-07 2007-06-18 Agents cytotoxiques comprenant de nouveaux taxanes

Country Status (22)

Country Link
US (1) US7667054B2 (fr)
EP (2) EP1669358A1 (fr)
JP (1) JP2008523019A (fr)
KR (1) KR20070085781A (fr)
CN (1) CN101094857A (fr)
AR (1) AR054100A1 (fr)
AU (1) AU2005313444B2 (fr)
BR (1) BRPI0518869A2 (fr)
CA (1) CA2588587A1 (fr)
DO (1) DOP2005000248A (fr)
EA (1) EA012625B1 (fr)
IL (1) IL183404A0 (fr)
MA (1) MA29103B1 (fr)
MX (1) MX2007006765A (fr)
MY (1) MY144632A (fr)
NO (1) NO20073033L (fr)
NZ (1) NZ555406A (fr)
PE (2) PE20110001A1 (fr)
TW (1) TW200637836A (fr)
UY (1) UY29249A1 (fr)
WO (1) WO2006061258A2 (fr)
ZA (1) ZA200704790B (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100056762A1 (en) 2001-05-11 2010-03-04 Old Lloyd J Specific binding proteins and uses thereof
DK1392359T4 (da) 2001-05-11 2013-06-10 Ludwig Inst For Cancer Res Ltd Specifikke bindingsproteiner og deres anvendelser.
US9090693B2 (en) * 2007-01-25 2015-07-28 Dana-Farber Cancer Institute Use of anti-EGFR antibodies in treatment of EGFR mutant mediated disease
US20080207743A1 (en) * 2007-02-28 2008-08-28 Rodger Lamb Biologically Active Taxane Analogs and Methods of Treatment
JP5618549B2 (ja) * 2007-03-15 2014-11-05 ルードヴィッヒ インスティテュート フォー キャンサーリサーチ リミテッド Ｅｇｆｒ抗体及びｓｒｃ阻害剤を用いる治療方法及び関連製剤
JP5532486B2 (ja) 2007-08-14 2014-06-25 ルードヴィッヒ インスティテュート フォー キャンサー リサーチ Ｅｇｆ受容体を標的とするモノクローナル抗体１７５ならびにその誘導体および用途
FR2947269B1 (fr) 2009-06-29 2013-01-18 Sanofi Aventis Nouveaux composes anticancereux
FR2949469A1 (fr) 2009-08-25 2011-03-04 Sanofi Aventis Derives anticancereux, leur preparation et leur application en therapeutique
US20110076232A1 (en) * 2009-09-29 2011-03-31 Ludwig Institute For Cancer Research Specific binding proteins and uses thereof
UY32913A (es) 2009-10-02 2011-04-29 Sanofi Aventis Nuevos maitansinoides y el uso de dichos maitansinoides para preparar conjugados con un anticuero
CN101851231A (zh) * 2010-05-27 2010-10-06 东北林业大学 一种多西紫杉醇新衍生物的合成方法及其在制备抗肿瘤药物中的应用
FR2963007B1 (fr) 2010-07-26 2013-04-05 Sanofi Aventis Derives anticancereux, leur preparation et leur application therapeutique
PL2872157T3 (pl) 2012-07-12 2020-07-13 Hangzhou Dac Biotech Co., Ltd Koniugaty wiążących komórkę cząsteczek ze środkami cytotoksycznymi
US10131682B2 (en) 2012-11-24 2018-11-20 Hangzhou Dac Biotech Co., Ltd. Hydrophilic linkers and their uses for conjugation of drugs to a cell binding molecules
JP6417421B2 (ja) 2014-02-28 2018-11-07 ハンジョウ ディーエーシー バイオテック シーオー．，エルティディ．Ｈａｎｇｚｈｏｕ Ｄａｃ Ｂｉｏｔｅｃｈ Ｃｏ．，Ｌｔｄ． 荷電連結体及び共役体のためのその使用
CN104693156A (zh) * 2014-10-22 2015-06-10 上海大学 9,10-二羟基-1-去氧紫杉醇类似物及其制备方法
CA2991973C (fr) 2015-07-12 2021-12-07 Suzhou M-Conj Biotech Co., Ltd. Lieurs de pontage pour la conjugaison d'une molecule de liaison cellulaire
US9839687B2 (en) 2015-07-15 2017-12-12 Suzhou M-Conj Biotech Co., Ltd. Acetylenedicarboxyl linkers and their uses in specific conjugation of a cell-binding molecule
KR20220147719A (ko) 2016-11-14 2022-11-03 항저우 디에이씨 바이오테크 씨오, 엘티디 결합 링커, 그러한 결합 링커를 함유하는 세포 결합 분자-약물 결합체, 링커를 갖는 그러한 결합체의 제조 및 사용
CN117980327A (zh) 2021-11-03 2024-05-03 杭州多禧生物科技有限公司 抗体的特异性偶联

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5703247A (en) * 1993-03-11 1997-12-30 Virginia Tech Intellectual Properties, Inc. 2-Debenzoyl-2-acyl taxol derivatives and methods for making same
FR2742751B1 (fr) * 1995-12-22 1998-01-30 Rhone Poulenc Rorer Sa Nouveaux taxoides, leur preparation et les compositions pharmaceutiques qui les contiennent
HK1049997B (en) * 1999-11-24 2007-02-23 Immunogen, Inc. Cytotoxic agents comprising taxanes and their therapeutic use
US6596757B1 (en) * 2002-05-14 2003-07-22 Immunogen Inc. Cytotoxic agents comprising polyethylene glycol-containing taxanes and their therapeutic use
EP1534674A4 (fr) * 2002-08-02 2007-11-28 Immunogen Inc Agents cytotoxiques renfermant des nouveaux taxanes puissants et utilisation therapeutique de ceux-ci

Also Published As

Publication number Publication date
US20060178427A1 (en) 2006-08-10
EP1824858A2 (fr) 2007-08-29
BRPI0518869A2 (pt) 2008-12-16
NZ555406A (en) 2011-02-25
TW200637836A (en) 2006-11-01
MY144632A (en) 2011-10-14
PE20061060A1 (es) 2006-11-14
EP1669358A1 (fr) 2006-06-14
NO20073033L (no) 2007-08-28
ZA200704790B (en) 2008-08-27
CN101094857A (zh) 2007-12-26
CA2588587A1 (fr) 2006-06-15
MX2007006765A (es) 2007-08-16
AR054100A1 (es) 2007-06-06
JP2008523019A (ja) 2008-07-03
EA012625B1 (ru) 2009-10-30
AU2005313444A1 (en) 2006-06-15
WO2006061258A3 (fr) 2006-09-28
DOP2005000248A (es) 2007-02-15
WO2006061258A2 (fr) 2006-06-15
US7667054B2 (en) 2010-02-23
AU2005313444B2 (en) 2011-11-10
PE20110001A1 (es) 2011-01-21
UY29249A1 (es) 2006-06-30
IL183404A0 (en) 2007-10-31
EA200701251A1 (ru) 2007-12-28
KR20070085781A (ko) 2007-08-27

Similar Documents

Publication Publication Date Title
MA28948B1 (fr) Composition pesticide
IL183404A0 (en) Cytotoxic agents comprising new taxanes
EP1719409A4 (fr) Composition insecticide
EP1893244A4 (fr) Agents pour l'imagerie
FI20050565A0 (fi) Ohjaussauvajärjestely
DK1740484T3 (da) Platform
BRPI0508066B1 (pt) Pesticida de piretróide
DE602005008239D1 (de) Gepfropfte fluorelastomere
EP2111484A4 (fr) Agent de brillance polyamine
DE602005018577D1 (de) Armstütze
UY3546Q (es) Maquina de juego
DE202005000407U1 (de) Arbeitsbühne
DE602005018177D1 (de) Drehzerstäubungskopf-lackiervorrichtung
UY3548Q (es) Maquina de juego
FR2871686B1 (fr) Composition anti-decoloration
ITMI20041447A1 (it) Composizione farmaceutica comprendente gabapentina
ITMI20040943A1 (it) Composizione farmaceutica cicatrizzante
DE602006007836D1 (de) Kontrastmittel
ES1058102Y (es) Lentilla terapeutica.
NO20042486L (no) Novel contrast agent
DE602005001303D1 (de) Pestizide Zusammensetzung
AT500775B2 (de) Spielkonsole
ES1058047Y (es) Juego de helice
SE0400990D0 (sv) Läkemedel
ES1056992Y (es) Juego de construccion.